Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04498689 | Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer | unknown | Phase 2 | 117 | Fudan UniversityOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT04216758 | Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer | unknown | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Jun 30, 2020 | clinicaltrials |
| NCT04449289 |
| Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery |
| unknown |
| Phase 2 |
| 100 |
| Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian FodorOTHER |
| 1 |
| Jun 26, 2020 |
| clinicaltrials |
| NCT04415385 | The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma | unknown | Phase 2 | 48 | Zhejiang Cancer HospitalOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04377048 | Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer | unknown | Phase 2 | 38 | National Taiwan University HospitalOTHER | 0 | May 6, 2020 | clinicaltrials |
| NCT04352023 | Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural | unknown | Phase 2 | 110 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 17, 2020 | clinicaltrials |
| NCT03850769 | Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT03885219 | Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT02635971 | Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 168 | Fudan UniversityOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT03139487 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY) | unknown | Phase 2 | 176 | Asan Medical CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT03638206 | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | unknown | Phase 1 / Phase 2 | 73 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Dec 11, 2019 | clinicaltrials |
| NCT03838029 | Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery(BC-PC) | unknown | Phase 2 | 210 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Nov 20, 2019 | clinicaltrials |
| NCT04101929 | Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen | unknown | Phase 2 | 126 | Fudan UniversityOTHER | 1 | Nov 5, 2019 | clinicaltrials |
| NCT02926183 | Study of NAC of GA Therapy for Patients With BRPC | unknown | Phase 2 | 60 | Wakayama Medical UniversityOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT03779464 | Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas | unknown | Phase 2 | 132 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT02737228 | Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 24 | CrystalGenomics, Inc.INDUSTRY | 1 | Jun 17, 2019 | clinicaltrials |
| NCT03941457 | Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 9 | Asclepius Technology Company Group (Suzhou) Co., Ltd.INDUSTRY | 1 | May 8, 2019 | clinicaltrials |
| NCT03634332 | Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC | unknown | Phase 2 | 35 | Pancreatic Cancer Research TeamOTHER | 1 | May 7, 2019 | clinicaltrials |
| NCT03929094 | Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT03825328 | A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) | unknown | Phase 2 | 30 | Yanqiao ZhangOTHER | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03815461 | Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03634501 | Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells | unknown | Phase 1 / Phase 2 | 200 | Xuanwu Hospital, BeijingOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT03662035 | Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer(ASPC) | unknown | Phase 2 | 30 | Changzhou No.2 People's HospitalOTHER | 0 | Sep 19, 2018 | clinicaltrials |
| NCT03662412 | Study of Sirolimus in Patients With Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 36 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT02450656 | Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer(M14AFS) | unknown | Phase 1 / Phase 2 | 320 | The Netherlands Cancer InstituteOTHER | 1 | Aug 27, 2018 | clinicaltrials |
| NCT03633734 | Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma | unknown | Phase 1 / Phase 2 | 49 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT03636308 | Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer(ASAGPAC) | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT03607643 | A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies | unknown | Phase 1 / Phase 2 | 160 | Leaf Vertical Inc.INDUSTRY | 1 | Jul 31, 2018 | clinicaltrials |
| NCT03502343 | Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer | unknown | Phase 2 | 52 | Yonsei UniversityOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT02758587 | Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) | unknown | Phase 1 / Phase 2 | 59 | NHS Greater Glasgow and ClydeOTHER | 1 | Mar 19, 2018 | clinicaltrials |
| NCT02978547 | The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma(Metformin 001) | unknown | Phase 2 | 20 | British Columbia Cancer AgencyOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02862015 | Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer Patients(Oncothermia) | unknown | Phase 2 | 100 | Seoul National University HospitalOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT03316326 | S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer | unknown | Phase 2 | 35 | National Taiwan University HospitalOTHER | 0 | Oct 20, 2017 | clinicaltrials |
| NCT01971281 | Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA) | unknown | Phase 1 / Phase 2 | 40 | NovoCure Ltd.INDUSTRY | 2 | Sep 13, 2017 | clinicaltrials |
| NCT03278015 | Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients | unknown | Phase 2 | 90 | Chinese PLA General HospitalOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT03167112 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer(Folfirinox) | unknown | Phase 2 | 20 | Petr KavanOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT03251365 | Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer | unknown | Phase 2 / Phase 3 | 42 | Hospital General de Ciudad RealOTHER | 1 | Aug 16, 2017 | clinicaltrials |
| NCT01729481 | Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer(ML22774) | unknown | Phase 2 | 150 | Ludwig-Maximilians - University of MunichOTHER | 1 | Jul 19, 2017 | clinicaltrials |
| NCT03204019 | A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor | unknown | Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 29, 2017 | clinicaltrials |
| NCT02461836 | Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1) | unknown | Phase 2 | 513 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 5, 2017 | clinicaltrials |
| NCT01964534 | Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer(AFUGEM) | unknown | Phase 2 | 114 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT03013712 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer(CARTEPC) | unknown | Phase 1 / Phase 2 | 60 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT02124317 | Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer(NAPSPAC) | unknown | Phase 2 | 60 | Chinese PLA General HospitalOTHER | 1 | Dec 22, 2016 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02587689 | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02726854 | Apatinib as Second-line Treatment of Advanced Pancreatic Cancer(Apslpanc) | unknown | Phase 2 | 30 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Dec 2, 2016 | clinicaltrials |
| NCT02329717 | Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma | unknown | Phase 2 | 50 | Phoenix Biotechnology, IncINDUSTRY | 1 | Sep 29, 2016 | clinicaltrials |
| NCT02863367 | A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer(OECTAPGAMPC) | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Aug 11, 2016 | clinicaltrials |
| NCT00689715 | Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas(EUS-EP) | unknown | Phase 2 / Phase 3 | 50 | Asan Medical CenterOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT02754180 | Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes | unknown | Phase 2 | 110 | Peking Union Medical College HospitalOTHER | 1 | Apr 28, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Aug 4, 2020source: clinicaltrials